First-line Treatment for Atrial Fibrillation in Cardiology and Geriatric Departments (ACFA)
Assessment of the Usual Choice for a First-line Treatment in Case of Atrial Fibrillation : Comparison Between Cardiology Department and Geriatric Unit.
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Metz Cedex 03, France, 57085
- CHR Metz-Thionville
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- having an atrial fibrillation
- cared in Cardiology department or in geriatric unit
Exclusion Criteria:
- having a mitral valvulopathy, or a valvular disease with a surgery indication
- having a valvular prosthesis
- history of valve reconstruction
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Hospitalization in Cardiology department
Patients cared by the Cardiology department
|
|
Hospitalization in Geriatric unit
Patients cared by the Geriatric unit
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Implementation of the recommendations about non-valvular atrial fibrillation
Time Frame: September 1st, 2014 to October 13, 2015
|
September 1st, 2014 to October 13, 2015
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Socio-demographic data
Time Frame: September 1st, 2014 to October 13, 2015
|
September 1st, 2014 to October 13, 2015
|
|
Etiologic factors of the atrial fibrillations
Time Frame: September 1st, 2014 to October 13, 2015
|
September 1st, 2014 to October 13, 2015
|
|
Use of supplementary examinations
Time Frame: September 1st, 2014 to October 13, 2015
|
September 1st, 2014 to October 13, 2015
|
|
Use of a standard geriatric assessment
Time Frame: September 1st, 2014 to October 13, 2015
|
September 1st, 2014 to October 13, 2015
|
|
Use of an assessment of the risks of thrombosis and bleeding
Time Frame: September 1st, 2014 to October 13, 2015
|
September 1st, 2014 to October 13, 2015
|
|
Choice of the anti-thrombosis treatment
Time Frame: September 1st, 2014 to October 13, 2015
|
September 1st, 2014 to October 13, 2015
|
|
Choice of the anti-arrhythmia treatment
Time Frame: September 1st, 2014 to October 13, 2015
|
September 1st, 2014 to October 13, 2015
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: NOEL BLETTNER, MD, CHR Metz-Thionville
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2015-05Obs-CHRMT
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.